Institutional investors hold a majority ownership of AMGN through the 80.63% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 2.4 Million shares of Amgen
TWO SIGMA ADVISERS LP Bought 1.7 Million shares of Amgen
MANAGED ACCOUNT ADVISORS LLC Bought 1.4 Million shares of Amgen